New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies

被引:42
作者
Husson, H
Manavalan, P
Akmaeva, VR
Russo, RJ
Cook, B
Richards, B
Barberio, D
Liu, DY
Cao, XH
Landes, GM
Wang, CJ
Roberts, BL
Klinger, KW
Grubman, SA
Jefferson, DM
Ibraghimov-Beskrovnaya, O
机构
[1] Genzyme Corp, Funct Genom, Framingham, MA 01701 USA
[2] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA
关键词
autosomal-dominant polycystic kidney disease; polycystin; PKD1; PKD2; SAGE; microarray; gene expression profiling; RT-PCR;
D O I
10.1016/j.ygeno.2004.03.009
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in the PKD1 or PKD2 gene, but cellular mechanisms of cystogenesis remain unclear. In an attempt to display the array of cyst-specific molecules and to elucidate the disease pathway, we have performed comprehensive high-throughput expression analysis of normal and ADPKD epithelia in a two-step fashion. First, we generated expression profiles of normal and cystic epithelia derived from kidney and liver using serial analysis of gene expression (SAGE). We found 472 and 499 differentially expressed genes with fivefold difference in liver and kidney libraries, respectively. These genes encode growth factors, transcription factors, proteases, apoptotic factors, molecules involved in cell-extracellular matrix interactions, and ion channels. As a second step, we constructed a custom cDNA microarray using a subset of the differentially regulated genes identified by SAGE and interrogated ADPKD patient samples. Subsequently, a set of differentially expressed genes was refined to 26 up-regulated and 48 downregulated genes with a p value of <0.01. This study may provide valuable insights into the pathophysiology of ADPKD and suggest potential therapeutic targets. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:497 / 510
页数:14
相关论文
共 79 条
[41]   EXPRESSION OF DIFFERENTIATION ANTIGENS AND GROWTH-RELATED GENES IN NORMAL KIDNEY, AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE, AND RENAL-CELL CARCINOMA [J].
KLINGEL, R ;
DIPPOLD, W ;
STORKEL, S ;
ZUMBUSCHENFELDE, KHM ;
KOHLER, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (01) :22-30
[42]  
KLINGEL R, 1991, VIRCHOWS ARCH B, V61, P189
[43]  
Lanoix J, 1996, ONCOGENE, V13, P1153
[44]   ASSOCIATION OF CYCLOSPORINE-A WITH ACQUIRED CYSTIC KIDNEY-DISEASE OF THE NATIVE KIDNEYS IN RENAL-TRANSPLANT RECIPIENTS [J].
LIEN, YHH ;
HUNT, KR ;
SISKIND, MS ;
ZUKOSKI, C .
KIDNEY INTERNATIONAL, 1993, 44 (03) :613-616
[45]   INHIBITION OF THE OXIDATIVE BURST RESPONSE OF N-FORMYL PEPTIDE-STIMULATED NEUTROPHILS BY SERUM AMYLOID-A PROTEIN [J].
LINKE, RP ;
BOCK, V ;
VALET, G ;
ROTHE, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (03) :1100-1105
[46]   Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells [J].
Liu, H ;
Bowes, RC ;
vandeWater, B ;
Sillence, C ;
Nagelkerke, JF ;
Stevens, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :21751-21759
[47]   POLYCYSTIC KIDNEY-DISEASE - ETIOLOGY, PATHOGENESIS, AND TREATMENT [J].
MARTINEZ, JR .
DM DISEASE-A-MONTH, 1995, 41 (11) :698-765
[48]  
Maser RL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134991
[49]  
Maxwell PJ, 2003, CANCER RES, V63, P4602
[50]  
Merta M, 1997, BIOCHEM MOL BIOL INT, V41, P619